Daisuke Toki

Adachi, 1238558, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette-Guérin (BCG) Instillation via Open-Ended Ureteral Catheters After Failure Using Double-J Stents.

A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette-Guérin (BCG) Instillation via Open-Ended Ureteral Catheters After Failure Using Double-J Stents.

Journal: IJU case reports

Published: August 09, 2025

High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma.

High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma.

Journal: Japanese journal of clinical oncology

Published: January 29, 2025

Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.

Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.

Journal: International urology and nephrology

Published: November 15, 2024

Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.

Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.

Journal: Anticancer research

Published: April 23, 2024

Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report.

Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report.

Journal: Diagnostic pathology

Published: August 21, 2023

Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy.

Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy.

Journal: Journal of robotic surgery

Published: March 29, 2023

Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

Journal: Japanese journal of clinical oncology

Published: March 29, 2022

Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy.

Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy.

Journal: In vivo (Athens, Greece)

Published: March 22, 2022

Urinary Tract Infection in Hemodialysis-Dependent End-Stage Renal Disease Patients.

Urinary Tract Infection in Hemodialysis-Dependent End-Stage Renal Disease Patients.

Journal: Research and reports in urology

Published: October 24, 2021

A specific promoter-type in ribonuclease L gene is associated with phagocytic activity in pigs.

A specific promoter-type in ribonuclease L gene is associated with phagocytic activity in pigs.

Journal: The Journal of veterinary medical science

Published: July 29, 2021

Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma.

Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma.

Journal: In vivo (Athens, Greece)

Published: May 30, 2021

Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab.

Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab.

Journal: In vivo (Athens, Greece)

Published: January 20, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026